| Aug 8 |
ProMIS Neurosciences Announces Second Quarter 2024 Financial Results and Recent Highlights
|
| Aug 6 |
ProMIS Neurosciences Announces Data on the Pathogenic Role of Toxic Misfolded SOD1 Aggregates in ALS Published in Acta Neuropathologica and Open Biology
|
| Aug 1 |
ProMIS Neurosciences to Participate in BTIG Virtual Biotechnology Conference 2024
|
| Jul 30 |
ProMIS Neurosciences Showcases Novel Vaccine Approach for Maximal Targeting of Toxic Amyloid-Beta Oligomers at the 2024 Alzheimer’s Association International Conference
|
| Jul 26 |
ProMIS Neurosciences Reports Positive Top-Line Data from its Phase 1a Alzheimer's Trial
|
| Jul 26 |
ProMIS Neurosciences Announces Up to $122.7 Million Private Placement Financing
|
